PCNA and neoplasm: Using immunocytochemical techniques, some researchers have demonstrated that hypoxic tumor cells are in a non- or slow-proliferating state and a majority of these cells are negative for proliferation markers, such as Proliferating Cell Nuclear Antigen (PCNA) or Bromodeoxyuridine (BrdU).